Antibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN1996412 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Hepatocyte Growth Factor Activator (HGFA) (AA 1-655) antibody
- Antibody type
- Polyclonal
- Antigen
- Other
- Description
- Affinity Purified
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- AA 1-655
- Isotype
- IgG
- Vial size
- 200 μg
- Storage
- This antibody can be stored at 2°C-8°C for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20°C to -70°C.
- Handling
- Preservative-Free. Sodium azide is recommended to avoid contamination (final concentration 0.05%-0.1%). It is toxic to cells and should be disposed of properly. Avoid repeated freeze-thaw cycles.
Submitted references Functional analysis of HGF/MET signaling and aberrant HGF-activator expression in diffuse large B-cell lymphoma.
Conformational lability in serine protease active sites: structures of hepatocyte growth factor activator (HGFA) alone and with the inhibitory domain from HGFA inhibitor-1B.
Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma.
Hepatocyte growth factor activator inhibitor type 1 is a specific cell surface binding protein of hepatocyte growth factor activator (HGFA) and regulates HGFA activity in the pericellular microenvironment.
Activation of hepatocyte growth factor in the injured tissues is mediated by hepatocyte growth factor activator.
Activation of the zymogen of hepatocyte growth factor activator by thrombin.
Tjin EP, Groen RW, Vogelzang I, Derksen PW, Klok MD, Meijer HP, van Eeden S, Pals ST, Spaargaren M
Blood 2006 Jan 15;107(2):760-8
Blood 2006 Jan 15;107(2):760-8
Conformational lability in serine protease active sites: structures of hepatocyte growth factor activator (HGFA) alone and with the inhibitory domain from HGFA inhibitor-1B.
Shia S, Stamos J, Kirchhofer D, Fan B, Wu J, Corpuz RT, Santell L, Lazarus RA, Eigenbrot C
Journal of molecular biology 2005 Mar 11;346(5):1335-49
Journal of molecular biology 2005 Mar 11;346(5):1335-49
Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma.
Kataoka H, Hamasuna R, Itoh H, Kitamura N, Koono M
Cancer research 2000 Nov 1;60(21):6148-59
Cancer research 2000 Nov 1;60(21):6148-59
Hepatocyte growth factor activator inhibitor type 1 is a specific cell surface binding protein of hepatocyte growth factor activator (HGFA) and regulates HGFA activity in the pericellular microenvironment.
Kataoka H, Shimomura T, Kawaguchi T, Hamasuna R, Itoh H, Kitamura N, Miyazawa K, Koono M
The Journal of biological chemistry 2000 Dec 22;275(51):40453-62
The Journal of biological chemistry 2000 Dec 22;275(51):40453-62
Activation of hepatocyte growth factor in the injured tissues is mediated by hepatocyte growth factor activator.
Miyazawa K, Shimomura T, Kitamura N
The Journal of biological chemistry 1996 Feb 16;271(7):3615-8
The Journal of biological chemistry 1996 Feb 16;271(7):3615-8
Activation of the zymogen of hepatocyte growth factor activator by thrombin.
Shimomura T, Kondo J, Ochiai M, Naka D, Miyazawa K, Morimoto Y, Kitamura N
The Journal of biological chemistry 1993 Oct 25;268(30):22927-32
The Journal of biological chemistry 1993 Oct 25;268(30):22927-32
No comments: Submit comment
No validations: Submit validation data